Regeneron (REGN) Reports Strong Eylea Sales; Cowen Reiterates Market Perform
Tweet Send to a Friend
Cowen reiterated a Market Perform rating on Regeneron Pharma (NASDAQ: REGN), and raised the price target to $575.00 (from $550.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
